Health Products

Paclitaxel for Injection

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
Y046843AB
Recalling Firm
Hospira Healthcare Corporation
600 - 1111 Dr. Frederik-Philips Blvd.
Saint-Laurent
H4M 2X6
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
600 - 1111 Dr. Frederik-Philips Blvd.
Saint-Laurent
H4M 2X6
Quebec
CANADA
A. Paclitaxel for InjectionSolutionDIN 02296624300 mg / 50 mL ( 6 mg/mL)

Introduction

Recalled products
  1. Paclitaxel for Injection

Reason

Recall due to inadvertent re-release of lots involved in the investigation of customer complaints received outside of Canada for visual vial defects which resemble a rust-like mark at the neck of the vial or black particles close to the neck of the vial.

Depth of distribution

Wholesalers, hospitals and pharmacies in Canada.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime